The Egyptian Drug Authority announced on Tuesday the withdrawal of the prescription drugs Mirage (500mg vial) and Saboctic (600mg FCT) from the market due to non-conformity with specifications in terms of their properties and appearance. The authority’s spokesman Aly Al-Ghamrawy said, in a statement, that an analysis of the drugs showed their non-conformity to regulations, prompting the pull. The authority also ordered the companies to take inventory and report their supplies to the pharmacy departments of the health affairs directorates in each governorate. Mirage is used as a broad-spectrum antibiotic to treat microbial skin infections, and Saboctic is used to treat nerve inflammation. IMAGE: A pharmacist searches for medicine at a pharmacy in Cairo, Egypt, November 17, 2016.

Source: Egypt Independent January 13, 2021 11:03 UTC